Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Background briefs
Filter     Order     Display # 
Date Item Title
01 Jul 2008 Companion Diagnostics Market May Not Be Fully Realized, Says Kalorama Analyst
13 Jun 2008 Honey, Silver Among Novel Wound Care Treatments
21 May 2008 The crowded field of IGF-1R antibodies
02 Apr 2008 Blockbuster drugs targeting PPAR
24 Mar 2008 DPP-IV Inhibitors: success attracts followers
19 Mar 2008 JAK Inhibitors in oncology and inflammation
04 Mar 2008 GLP-1: an attractive and validated target with ample space for improvement
25 Feb 2008 Biologics drive innovation in the drug pipeline for systemic lupus erythematosus
18 Feb 2008 Antagonists of IL-12/-23 challenge the anti-TNF antibodies in psoriasis
11 Feb 2008 2008 is a decisive year for the validation of the asthma target interleukin-13
04 Feb 2008 Syk Kinase: an anti-inflammatory target with first clinical proof of concept
28 Jan 2008 GM-CSF: an anti-inflammatory target on the rise
22 Jan 2008 Update on Death Receptor Targeting after a decade of R&D
15 Jan 2008 GlyT1 Inhibition: A novel approach to treat schizophrenia
10 Jan 2008 On the search for the right spectrum CDK inhibitor
08 Jan 2008 Botulinum toxin: a story of success
18 Dec 2007 Revival of a B-cell target: the CD19 antigen
10 Dec 2007 The Neurokinin Receptors: Targets with wide therapeutic potential
04 Dec 2007 Emerging new classes of HIV antiretriviral therapy
26 Nov 2007 Selectivity governs the development potential of muscarinic receptor agonists & antagonists
20 Nov 2007 Progress with the new class of the HIV fusion & entry inhibitors
14 Nov 2007 New generations of Non-Nucleoside Reverse Transcriptase Inhibitors with improved HIV resistance profile
06 Nov 2007 Higher specificity provides opportunity for safe and effective anti-arrhythmic drugs
29 Oct 2007 The AMPA receptor: a versatile target for CNS diseases
24 Oct 2007 Selectivity decides upon future of next generation p38 MAPK inhibitors
18 Oct 2007 The next generations of Her2 targeting molecules in development
09 Oct 2007 Attention-deficit hyperactivity disorder (ADHD): what's in the pipeline?
02 Oct 2007 Toll-Like Receptors as a target in cancer, allergy, sepsis and viral diseases
25 Sep 2007 The c-Met/HGF pathway: an attractive target for small molecules and biologics
17 Sep 2007 The selectivity issue of aurora kinase inhibitors
11 Sep 2007 BACE Inhibitors & gamma Secretase Modulators: Prime drug targets for Alzheimer's disease
04 Sep 2007 The success of Rituxan creates a rich pipeline of improved CD20 antibodies
28 Aug 2007 The next generation of proteasome inhibitors
17 Aug 2007 Beta-amyloid: a maturing target for diagnosis and treatment of Alzheimer's disease
 
<< Start < Prev 1 Next > End >>
Results 1 - 34 of 34

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Integrin Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonistgs & Antagonists

Order Now

Subscribe La Merie Biologics